BackStatera BioPharma Overview

Statera BioPharma Total Revenue

Revenue analysis for STAB.

Quarterly Revenue

$670473.00
↑ 183.48% YoY

As of Sep 2022

Annual Revenue (TTM)

$3.69M
↑ 1459.14% YoY

Trailing 12 months ending Sep 2022

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin